N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide

C23H29N5O2S — CID 3228342

IUPACN-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide
SMILESCC(C)Cn1c(=O)c2ccccc2n2c(SCC(=O)NCCC3=CCCCC3)nnc12
InChIInChI=1S/C23H29N5O2S/c1-16(2)14-27-21(30)18-10-6-7-11-19(18)28-22(27)25-26-23(28)31-15-20(29)24-13-12-17-8-4-3-5-9-17/h6-8,10-11,16H,3-5,9,12-15H2,1-2H3,(H,24,29)
InChIKeyLYXPKCNTEYKAKU-UHFFFAOYSA-N
MW439.59 g/mol
LogP3.80
Rot. Bonds8

About N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide

N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide (PubChem CID 3228342) has the molecular formula C23H29N5O2S and a molecular weight of 439.59 g/mol. Its IUPAC name is N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide.

Molecular Properties

Compound NameN-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide
PubChem CID3228342
Molecular FormulaC23H29N5O2S
Molecular Weight439.59 g/mol
Exact Mass439.20
IUPAC NameN-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide
SMILESCC(C)Cn1c(=O)c2ccccc2n2c(SCC(=O)NCCC3=CCCCC3)nnc12
InChIInChI=1S/C23H29N5O2S/c1-16(2)14-27-21(30)18-10-6-7-11-19(18)28-22(27)25-26-23(28)31-15-20(29)24-13-12-17-8-4-3-5-9-17/h6-8,10-11,16H,3-5,9,12-15H2,1-2H3,(H,24,29)
InChIKeyLYXPKCNTEYKAKU-UHFFFAOYSA-N
XLogP3.80
TPSA81.29 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500439.59
LogP ≤ 53.80
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide?
The IUPAC name of N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide (CID 3228342) is N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide.
What is the SMILES notation for N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide?
The canonical SMILES for N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide is CC(C)Cn1c(=O)c2ccccc2n2c(SCC(=O)NCCC3=CCCCC3)nnc12.
What is the InChIKey of N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide?
The InChIKey is LYXPKCNTEYKAKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H29N5O2S/c1-16(2)14-27-21(30)18-10-6-7-11-19(18)28-22(27)25-26-23(28)31-15-20(29)24-13-12-17-8-4-3-5-9-17/h6-8,10-11,16H,3-5,9,12-15H2,1-2H3,(H,24,29).
What are the key properties of N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide?
N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide has a molecular weight of 439.59 g/mol, XLogP of 3.80, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(cyclohexen-1-yl)ethyl]-2-[[4-(2-methylpropyl)-5-oxo-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]sulfanyl]acetamide is sourced from PubChem (CID 3228342), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).